Incidence and analysis of campylobacteriosis cases in the Czech Republic in 1997–2017
Authors:
M. Špačková 1; K. Kolářová 1; M. Gašpárek 2
Authors‘ workplace:
Oddělení epidemiologie infekčních nemocí, Centrum epidemiologie a mikrobiologie, Státní zdravotní ústav, Praha
1; Národní referenční centrum pro analýzu epidemiologických dat, Oddělení biostatistiky, Státní zdravotní ústav, Praha
2
Published in:
Epidemiol. Mikrobiol. Imunol. 68, 2019, č. 3, s. 122-130
Category:
Original Papers
Overview
Aim: The aim of our study was to conduct analysis of reported epidemiological data on human campylobacteriosis in the Czech Republic (CZ) from 1997 to 2017 and to summarize the current knowledge about the disease.
Methods: We conducted a descriptive epidemiological analysis of data on campylobacteriosis cases reported to the national surveillance system of infectious diseases in the CZ (EpiDat) from 1997 to 2017. MS Excel 2010 and statistical program R were used for data management and analysis. The incidence maps were created using the ECDC Map Maker tool (EMMa).
Results: Overall, 411 699 campylobacteriosis cases (average annual incidence of 188.9/ 100 000) were reported in the CZ from 1997 to 2017. Between 1997 and 2005, the annual incidence of campylobacteriosis was increasing sharply, but it showed a fairly stable trend over the last decade. The highest average age-specific incidence of 1 068.5/100 000 was observed in the age group 1–4 years followed by <1 year-olds with 814.7/100 000. The highest average annual incidence by administrative region was reported in the Moravian-Silesian Region (297.1/100 000) and Southern Moravia Region (274.0/100 000). A total of 52 398 cases (12.7%) required hospitalization, and 84 campylobacteriosis-related deaths (0.02%) were recorded. Nevertheless, campylobacteriosis was identified as the direct cause of death in only one patient. In the CZ, campylobacteriosis mainly occurs as sporadic cases or family clusters (>99% of cases). The most common etiologic agent of campylobacteriosis is Campylobacter jejuni.
Conclusions: Since 2007, campylobacteriosis is the most common food- and water-borne disease in the CZ. Given the high number of cases, this infectious disease is a rising public health concern. The prevention should be focused on the main risk groups, i.e. children under 5 years of age, who are the most affected, and those older than 80 years, who have more complications and a higher hospitalization rate.
Keywords:
Czech Republic – Campylobacter spp. – campylobacteriosis – food- and water-borne diseases
Sources
1. EFSA, ECDC, The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016. EFSA Journal, 2017;15(12):5077.
2. Hansson I, Sandberg M, Habib I, et al. Knowledge gaps in control of Campylobacter for prevention of campylobacteriosis. Transboundary and emerging diseases, 2018;65:30–48.
3. Kirk MD, Pires SM, Black RE, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS medicine, 2015;12(12):e1001921.
4. Reay DJM. Report of the Departmental Committee appointed by the Board of Agriculture and Fisheries to inquire into and report upon the subject of agricultural education in England and Wales in Parliament. 1908. Printed for HMSO, by McCorquodale & Co., Ltd.
5. Vinzent R. Abortion following severe septicemia due to Vibrio fetus. Bull. Acad. nat. méd, 1947;131:90.
6. Hochel I. Metody detekce a charakterizace Campylobacter sp. Chemické listy, 2009;103: 814–822.
7. Skirrow M, Campylobacter enteritis: a” new” disease. Br Med J, 1977;2(6078):9–11.
8. Sebald M, Veron M. Base DNA content and classification of Vibrios. in Annales de l’Institut Pasteur. 1963.
9. Turková M. Campylobacter jejuni. Diplomová práce. 2014, Univerzita Karlova.
10. On SL, Isolation, identification and subtyping of Campylobacter: where to from here? Journal of microbiological methods, 2013;95(1):3–7.
11. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, et al. Global epidemiology of Campylobacter infection. Clinical microbiology reviews, 2015;28(3):687–720.
12. Beneš J. Infekční lékařství. 2009: Galen.
13. Man SM. The clinical importance of emerging Campylobacter species. Nature reviews Gastroenterology & hepatology, 2011;8(12):669.
14. Julák J. Klinicky významné bakterie. 2012, Praha: Triton.
15. Acke E, Whyte P, Jones B, et al. Prevalence of thermophilic Campylobacter species in cats and dogs in two animal shelters in Ireland. Veterinary Record, 2006;158(2):51–54.
16. Konicek C, Vodrážka P, Barták P, et al. Detection of Zoonotic Pathogens in Wild Birds in the Cross-Border Region Austria–Czech Republic. Journal of wildlife diseases, 2016;52(4): 850–861.
17. Greenwood D. Lékařská mikrobiologie: přehled infekčních onemocnění: patogeneze, imunita, laboratorní diagnostika a epidemiologie. 1999: Grada publishing.
18. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. International Journal of Medical Microbiology, 2010;300(4):205–211.
19. Doorduyn Y, Van Den Brandhof W, Van Duynhoven Y, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiology & Infection, 2010;138(10):1391–1404.
20. Sheppard SK, Dallas JF, Strachan NJ, et al. Campylobacter genotyping to determine the source of human infection. Clinical Infectious Diseases, 2009;48(8):1072–1078.
21. Bednář M, Fraňková V, Schindler J, et al. Lékařská mikrobiologie. Praha: Marvil, 1996.
22. Patrick ME, Gilbert MJ, Blaser MJ, et al. Human infections with new subspecies of Campylobacter fetus. Emerging infectious diseases, 2013;19(10):1678.
23. Feodoroff B, de Haan CP, Ellström P, et al. Clonal distribution and virulence of Campylobacter jejuni isolates in blood. Emerging infectious diseases, 2013;19(10):1653.
24. Blaser MJ, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections, in Campylobacter, Third Edition. American Society of Microbiology, 2008:99-121.
25. Poropatich KO, Walker CLF, Black RE, Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. Journal of health, population, and nutrition, 2010;28(6):545.
26. Bardon J, Kolar M, Cekanova L, et al. Prevalence of Campylobacter jejuni and its resistance to antibiotics in poultry in the Czech Republic. Zoonoses and public health, 2009; 56(3):111–116.
27. Bardoň J, Pudová V, Koláčková I, et al. Virulence and antibiotic resistance genes in Campylobacter spp. in the Czech Republic. Epidemiologie, mikrobiologie, imunologie: casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti JE Purkyne, 2017;66(2):59–66.
28. Schielke A, Rosner BM, Stark K. Epidemiology of campylobacteriosis in Germany–insights from 10 years of surveillance. BMC infectious diseases, 2014;14(1):30.
29. Havelaar AH, van Pelt W, Ang CW, et al. Immunity to Campylobacter: its role in risk assessment and epidemiology. Critical reviews in microbiology, 2009;35(1):1–22.
30. Jansen A, Stark K, Kunkel J, et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC infectious diseases, 2008;8(1):143.
31. Unicomb LE, Fullerton KE, Kirk MD, et al. Outbreaks of campylobacteriosis in Australia, 2001 to 2006. Foodborne Pathogens and Disease, 2009;6(10):1241–1250.
32. Informační systém hlášení infekčních nemocí EpiDat. 2018. Orgány ochrany veřejného zdraví České republiky, Státní zdravotní ústav.
33. The R Foundation, The R Project for Statistical Computing. 2018.
34. Microsoft Office 10, Microsoft Excel. 2018.
35. European Centre for Disease Prevention and Control, ECDC Map Maker tool (EMMa). 2019.
36. Český statistický úřad. Spotřeba potravin – 2017. 2018 4. 12. 2018. Dostupné na www: https://www.czso.cz/csu/czso/spotreba-potravin-2017.
37. European Centre for Disease Prevention, Annual Epidemiological Report. 2011: ECDC, European Centre for Disease Prevention and Control.
38. Nichols GL, Richardson JF, Sheppard SK, et al. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ open, 2012;2(4):e001179.
39. Lal A, Hales S, French N, et al. Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One, 2012;7(4):e31883.
40. Roubalová M. Situační a výhledová zpráva – drůbež a vejce 2014. Dostupné na www: http://www.apic-ak.cz/data_ak/15/k/DaV/DaVSVZ1411.pdf.
41. Tam CC, Higgins CD, Neal KR, et al. Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England. Emerging infectious diseases, 2009;15(9):1402.
42. Bardoň J. Ten years of monitoring of thermotolerant Campylobacter in the human food chain in the Czech republic. Zoonoses – Protection of public and animal health, 2016:22.
43. Bardoň J, Kolář M, Karpíšková R, et al. Prevalence of thermotolerant Campylobacter spp. in broilers at retail in the Czech Republic and their antibiotic resistance. Food Control, 2011; 22(2):328–332.
44. Bardon J, Ondruskova J, Oslikova M, et al. Zoonotic potential of raw cow’s milk in the Czech Republic. Klinicka mikrobiologie a infekcni lekarstvi, 2012;18(2):32–37.
45. Kuhn K, Nielsen E, Mølbak K, et al. Epidemiology of campylobacteriosis in Denmark 2000–2015. Zoonoses and public health, 2018;65(1):59–66.
46. Skirrow M. A demographic survey of campylobacter, salmonella and shigella infections in England: a Public Health Laboratory Service survey. Epidemiology & Infection, 1987;99(3):647–657.
47. Maďar R, Podstatová R, Řehořová J. Prevence nozokomiálních nákaz v klinické praxi. 2006: Grada Publishing as.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2019 Issue 3
Most read in this issue
- Incidence and analysis of campylobacteriosis cases in the Czech Republic in 1997–2017
- Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic
- Antiviral adoptive immunotherapy using antigen-specific T cells in allogeneic hematopoietic stem cell transplant recipients
- A high prevalence of viral hepatitis C in a socially excluded Roma community in Brno